Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case rep
- PDF / 1,336,689 Bytes
- 4 Pages / 595.276 x 790.866 pts Page_size
- 70 Downloads / 178 Views
(2020) 15:335
CASE REPORT
Open Access
Successfully treatment of application awake extracorporeal membrane oxygenation in critical COVID-19 patient: a case report Junyi Tang, Wencan Li, Fanli Jiang and Tao Wang*
Abstract Background: A newly infectious diseases named coronavirus disease 2019 (COVID-19) emerged in China and now has spread in many countries, and constituted a public health emergency of international concern. Extracorporeal membrane oxygenation (ECMO) is used as salvage therapies in critical COVID-19 patients with respiratory/cardiac failure. Case presentation: A 49-year-old female patient was diagnosed with COVID-19 and progressed to critical cases, she was successfully treated with the application of awake extracorporeal membrane oxygenation. This case is the first reported successfully treatment of application awake ECMO in critical COVID-19 patient in China. Conclusions: Here we present the first reported successfully treatment of application awake ECMO in critical COVID-19 patient, however, whether awake ECMO can be widely used in the treatment of critical COVID-19 patients need more practice. Keywords: Awake extracorporeal membrane oxygenation, COVID-19, Case report
Background A newly infectious diseases COVID-19 emerged in China and now had spread in many countries, and constituted a public health emergency of international concern. ECMO was used as salvage therapies in critical COVID-19 patients with respiratory/cardiac failure. However, due to the high cost, complex technology and uneven resource distribution, cases of ECMO used in COVID-19 patients were rare. Here we presented the first case of successfully treated critical COVID-19 patient with awake ECMO in China, this report illustrated why, when and how we applying awake ECMO in critical COVID-19 patient.
* Correspondence: [email protected] Department of Thoracic and Cardiovascular Surgery, The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, 116 Changjiangnan Road, Zhuzhou 412007, Hunan, China
Case presentation On January 28, 2020, a 49-year-old female patient was transferred to our hospital for further treatment after being diagnosed with COVID-19. At admission, She presented with fever, cough, sputum, and mild dyspnea. Her body temperature was 38 °C, blood oxygen saturation (SPO2) was 93% under ambient air, oxygen inhalation was immediately given by nasal catheter. After admission, levofloxacin and human immunoglobulin were injected into the veins, recombinant with human interferon a2b atomized inhalation. On the 5th day of admission, the disease deteriorated and her mental state was poor, body temperature was 38.8 °C, blood gas analysis: PO2 49 mmHg, PCO2 38 mmHg. She suffered from type I respiratory failure, which conformed to the diagnostic criteria of severe COVID-19 according to the COVID-19 health guidelines of China national health commission. On the 8th day, oxygen inhalation was given by oxygen storage mask (8 L/min), SPO2 was 93%, blood gas analysis: PO2 49 mmHg, PCO2 38 mmHg,
© The Author(s). 2020 Open Access
Data Loading...
